| 000 | 01904nam a2200493 4500 | ||
|---|---|---|---|
| 001 | BDZ0000925634 | ||
| 003 | StDuBDS | ||
| 005 | 20180923141540.0 | ||
| 008 | 960912s1996 enka || 001 ||eng d | ||
| 010 | _a96033800 | ||
| 020 |
_a9780080427928 : _c£140.00 |
||
| 020 | _a0080427928 | ||
| 040 |
_aUk _cUk _dStDuBDSZ |
||
| 049 | _aYQAA | ||
| 072 | 7 |
_aTCB _2thema |
|
| 072 | 7 |
_aPNF _2thema |
|
| 072 | 7 |
_aKND _2thema |
|
| 072 | 7 |
_aTDCW _2thema |
|
| 082 | 0 | _a615.1901 RIL | |
| 245 | 0 | 0 |
_aDevelopment and validation of analytical methods / _cedited by Christopher M. Riley and Thomas W. Rosanske. |
| 250 | _a1st ed. | ||
| 260 |
_aNew York, N.Y. : _bPergamon ; _aOxford : _bElsevier, _c1996. |
||
| 300 |
_ax, 352p. : _bill. ; _c24cm. |
||
| 440 | 0 |
_aProgress in pharmaceutical and biomedical analysis ; _vv. 3 |
|
| 490 | 0 |
_aProgress in pharmaceutical and biomedical analysis ; _vv. 3 |
|
| 500 | _aIncludes index. | ||
| 504 | _aIncludes bibliographical references and index. | ||
| 520 | 8 | _aThis text is intended to serve as a guide to the analyst in terms of the issues and parameters that must be considered in the development and validation of analytical methods. It also deals with other related factors such as method development, data acquisition, automation and cleaning validation. | |
| 650 | 0 |
_aDrugs _xAnalysis _xMethodology |
|
| 650 | 7 |
_aPharmaceutical chemistry & technology _2thema |
|
| 650 | 7 |
_aManufacturing industries _2thema |
|
| 650 | 7 |
_aAnalytical chemistry _2thema |
|
| 650 | 7 |
_aBiotechnology _2thema |
|
| 650 | 1 | 2 |
_aChemistry, Pharmaceutical _xmethods |
| 650 | 2 | 2 |
_aPharmaceutical Preparations _xanalysis |
| 653 | 0 |
_aDrugs _aChemical analysis |
|
| 700 | 1 |
_aRiley, C. M. _q(Christopher M.) |
|
| 700 | 1 | _aRosanske, Thomas W. | |
| 700 | 1 | _aRiley, Christopher M. | |
| 902 | _a170814 | ||
| 907 |
_a.b10033981 _bmain _c- |
||
| 942 | _n0 | ||
| 998 |
_b1 _c010831 _dm _ea _f- _g0 |
||
| 999 |
_c545 _d545 |
||